发明名称 Low dose entecavir formulation and use
摘要 Compositions containing a low dose of entecavir are administered on a daily basis to treat hepatitis B virus infection and/or co-infections. Formulations for the oral administration of a low dose of entecavir are provided. Other pharmaceutically active substances can be included in the entecavir composition or can be separately administered for the treatment of hepatitis B virus infection or for the treatment of co-infected patients.
申请公布号 EP1642582(A1) 申请公布日期 2006.04.05
申请号 EP20050020938 申请日期 2001.01.26
申请人 BRISTOL-MYERS SQUIBB COMPANY 发明人 SPROCKEL, OMAR L.;DESAI, DIVYAKANT;HARIANAWALA, ABIZER;FAKES, MICHAEL G.
分类号 A61K31/52;A61K9/14;A61K9/20;A61K9/36;A61K9/48;A61K31/522;A61K47/02;A61K47/10;A61K47/12;A61K47/20;A61K47/26;A61K47/32;A61K47/36;A61K47/38;A61K47/42;A61P1/16;A61P31/20 主分类号 A61K31/52
代理机构 代理人
主权项
地址